According to the Centers for Disease Control and
Prevention, every day, more than 6,700 people are treated in U.S. emergency
departments for drug misuse or abuse. In 2011, the most recent year for which
data is available, the agency estimates that drug use or misuse resulted in
about 2.5 million hospital emergency department visits in the U.S. Add to that
thousands of patients presenting to emergency departments nationwide with
suspected exposure to poisons or other types of toxins, and you begin to
understand the scope of testing that toxicology labs serving the needs of
today?s busy emergency departments are expected to perform.
Fortunately, the technology used to investigate potential
toxic exposures continues to advance, and liquid chromatography-tandem mass
spectrometry (LC-MS/MS) now plays an essential role in these analyses. Join AACC
for this 60-minute webinar and hear Dr. Kara Lynch of the University of
California, San Francisco describe how today's toxicology labs are using
LC-MS/MS to provide timely and accurate information that emergency department
clinicians can use to make life-saving treatment decisions.
(This is a recorded version of an AACC live webinar that was held June 3, 2015).